The procedure was performed with the guidance of digital subtraction angiography (DSA). Hepatic artery angiography was performed with a Yashiro-type or 5-F RH catheter (Terumo) to assess the location, number, size, and blood supply of target tumors. Subsequently, a microcatheter (Progreat; Terumo, Ann Arbor, MI, USA) was inserted into the feeding artery of tumors. Intra-arterial administration consisted of 40–60 mg of epirubicin (Pharmorubicin; Pfizer, Wuxi, China) mixed with 5–20 ml of lipiodol (Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, China). Embolization was stopped following stasis of the contrast agent flow. When needed, further embolization was performed with Embosphere (100–300 μm) to achieve stasis.
5 f rh catheter
Manufactured by Terumo
Sourced in Japan
The 5-F RH catheter is a diagnostic medical device used for cardiac procedures. It is a flexible, thin tube that can be inserted into a patient's blood vessel to perform various diagnostic tests or treatments. The catheter has a diameter of 5 French (approximately 1.67 millimeters) and is designed for right-heart catheterization, a procedure used to assess the function of the right side of the heart.
Automatically generated - may contain errors
Lab products found in correlation
Pharmorubicin, by Pfizer (3 mentions)
2.7 f microcatheter, by Terumo (3 mentions)
Progreat, by Terumo (2 mentions)
Microcatheter, by Terumo (2 mentions)
Lipiodol, by Jiangsu Hengrui Medicine (1 mentions)
Lipiodol, by Guerbet (1 mentions)
Epirubicin, by Pfizer (1 mentions)
0.035 inch hydrophilic guidewire, by Terumo (1 mentions)
8 protocols using 5 f rh catheter
1
Transarterial Chemoembolization for Liver Tumors
2
Standardized TACE Procedure for Tumor Treatment
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The TACE procedure is consistent across centers, and as described in our previous report on the TACE procedure (10 (link)), all TACE procedures were performed by 2 experienced minimally invasive interventionalists under local anesthesia through a traditional femoral approach. After routine angiography using a 5F RH catheter (Terumo, Tokyo, Japan), superselective arterial cannulation with a microcatheter (Terumo) was used to access the branch of the feeding artery to the tumor. Doxorubicin (Haizheng Pharmaceutical, Taizhou, China) and lipiodol (Laboratoire Guerbet, Paris, France) were thoroughly mixed and injected into the tumor-nourishing blood vessels and then 560–710 μm gelatin sponge particles (ALICON Pharmaceutical, Hangzhou, China) were administered until blood flow almost stopped. The dosage of lipiodol was 5–20 mL, and the dosage of doxorubicin was 50–70 mg. The actual dose was based on the patient's liver function status, tumor burden, and the patient's body surface area.
3
Chemoembolization and Microwave Ablation for Liver Tumors
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Transcatheter arterial chemoembolization was performed in all patients. After introduction of a 5F-RH catheter (Terumo, Tokyo, Japan) through the femoral artery, hepatic artery angiography was performed and the location, number, size, and blood supply of tumors evaluated. Next, a 2.7F micro-catheter (Terumo) was super-selectively inserted into the arteries feeding the tumors and lobaplatin (50 mg) was infused, followed by slow injection of an emulsion of epirubicin (30 mg) mixed with Lipiodol (5–15 mL). Gelatin sponge particles (150–350 µm; Alicon, Hangzhou, China) were injected until the flow was static and full saturation of the feeding arteries had been achieved (16 (link)). Liver and kidney function were evaluated 10 days after TACE prior to administering MWA to patients receiving combined therapy.
4
Selective and Superselective Angiography Techniques
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The angiography was performed using the Allura Xper FD20 system (Philips, Amsterdam, the Netherlands). For vascular access, a 5-F sheath was introduced in the right femoral artery. In all patients, selective and superselective angiograms were obtained, including the late (portal venous) phase. A selective angiography was performed using a 5-F RH catheter (Terumo, Tokyo, Japan) positioned in the celiac trunk and in the superior mesenteric artery with an automated injection of 35 mL of iodinated contrast material at a rate of 5–6 mL/s with 300 psi of pressure. A superselective angiography was performed with an automated injection of 2.5 mL of iodinated contrast material via a 2.8-F microcatheter system (Renegade Hi-Flo Fathom™; Boston Scientific, Natick, USA) with 500 psi of pressure. The definition and evaluation of the arterial hemorrhage for an angiography was identical to a multidetector CT and was separately analyzed using selective and superselective angiography. Similar to multidetector CT imaging, the angiography was reviewed by two experienced radiologists (SUN, ZHOU.), and decisions were made based on consensus.
5
Transarterial Chemoembolization for Hepatocellular Carcinoma
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The TACE procedure began with routine disinfection, followed by towel spreading and administration of local anesthesia with 2% lidocaine. A 5-F sheath was introduced into each patient's femoral artery using the Seldinger technique (19 (link)), and a 5-F RH catheter (Terumo Corporation) was then used, through which arteriography of the celiac trunk, superior mesenteric artery and hepatic arteries was successively performed to collect an overview of the hepatic arterial blood supply and to evaluate the location, number and size of HCC tumors. A 2.7-F microcatheter (Terumo Corporation) was employed for superselection of the blood supply artery, and angiography confirmed that the microcatheter was accurately positioned. Once the target artery was catheterized, a 1:1 mixed suspension of iodized oil (1–10 ml; Lipiodol Ultra-Fluide; Yantai Luyin Pharmaceutical Co., Ltd.) and epirubicin (20–40 mg; Pharmorubicin; Pfizer, Inc.) was infused into the artery through the catheter, depending on liver function and tumor size. Finally, gelatin sponge particles (Gelfoam; Jiangxi Xiangen Medical Technology Development Co., Ltd.) were infused to embolize the artery until no tumor staining was found after repeated angiography. Finally, the guidewire and catheters were removed, and the femoral artery was compressed for 10 min to secure hemostasis at the puncture site.
6
Transarterial Chemoembolization for HCC
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
In this group of patients, TACE treatment involved selection of superficial femoral artery using the Seldinger technique (manipulation of a 5 F R-H catheter to the right-hand side; Terumo, Tokyo, Japan) into the peritoneal dry artery, and the tumor blood supply into the arteries was confirmed by angiography. Using an angiography image as a reference, the microcatheter (Progreat; Terumo, Tokyo, Japan) was then guided to the tumor arterial blood supply. Through the microcatheter, conventional chemoembolization was conducted by injecting emulsified liquids of iodized oil (approximately 30 ml; Andre Guerbet, Aulnay-sous-Bois, France) and pirarubicin (20 mg/m2) into the supply artery until the flow was stopped or reflux was noted. Chemoembolization drug dosage depended on the tumor size and vascularity. If a hepatic arteriovenous fistula or hepatic artery portal vein fistula was observed, the appropriate size of gelatin sponge was selected according to the size of fistula for the embolization treatment of fistula. Liver-enhanced computed tomography (CT) review was typically performed within 6-8 weeks to determine the next treatment plan. For those patients with HCC tumors in challenging locations, we employed ISI to further strengthen the control of locally residual active lesions.
7
Tumor Feeding Artery Identification and Embolization
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
To determine all the feeding arteries of the tumor, angiography of the abdominal trunk and superior mesenteric artery is performed with a 5F RH catheter (Terumo, Tokyo, Japan). Angiography of the left gastric artery, bilateral phrenic artery, right renal artery, and bilateral internal thoracic artery were also performed if necessary. Then, 5-8 mL of lipiodol, 1 mL of polyvinyl alcohol (PVA) foam embolization particles (COOK), 30 mg of epirubicin (Pfizer, New York, USA), and 22–25 mL of ioversol were mixed and emulsified. The target artery was catheterized with a 2.7F microcatheter (Terumo). Under the guidance of digital subtraction angiography (DSA), the target artery was embolized by the mixture. This process is shown in Fig. 2 .
8
Transarterial Chemoembolization for Tumor Treatment
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The transarterial chemoembolization procedure was performed under conscious sedation in an interventional suite by board-certified interventional radiologists in our center. Under local anesthesia using 5% lidocaine, the puncture of the common femoral artery was performed using the Selinger technique, after which a 5F RH catheter (Terumo, Tokyo, Japan) was introduced with a combination of the 0.035-inch hydrophilic guidewire (Terumo, Tokyo, Japan) to catheterize the celiac, superior mesenteric artery, and any suspected artery feeding the tumor. Digital subtraction angiography was performed to evaluate tumor location and size. The distal target artery was super selectively catheterized with a microcatheter (Terumo, Tokyo, Japan). Then, chemoembolization was performed using an emulsion of epirubicin (20–40mg; Pharmorubicin; Pfizer, Wuxi, China) in the iodized oil (1–10ml; Lipiodol Ultra-Fluide; Hengrui, Jiangsu, China), depending on liver function, tumor size, and vascular supply. Further embolization with gelatin sponge particles (Hangzhou Alc, Hangzhou, China) was finally performed until arterial flow stasis and no tumor staining after repeat angiography.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!